New SEC Form D filing
Vetmab Biosciences, Inc., 2026-09-29
A new SEC Form D private-offering notice from San Diego, CA, a $11,944,990 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Veterinary biopharmaceutical company developing monoclonal antibody therapeutics for dogs and cats
Filed 3 days agoFiled to raise $11,944,990First money in 2026-09-17Raised so far $11,439,990HQ (as filed) San Diego, CASector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified vetmab.bio↗Named in the filing 5 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Kindora PBC, 2026-09-29, $1.2M, Oakland, CA
- Sialia Therapeutics, Inc., 2026-09-29, $1.5M, Irvine, CA
- Upstream Metabolics, Inc., 2026-09-29, $150K, Lafayette, CA
- Conexeu Sciences Inc., 2026-09-29, $31K, Reno, NV
- CHERUB TECHNOLOGIES, INC., 2026-09-29, $850K, Burbank, CA
- GENHEALTH, INC., 2026-09-29, $16.5M, Vienna, VA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.